×
FLOYD CHRISTOPHER HOLSINGER
USA
Dr. Chris Holsinger is Professor and Chief of Head and Neck Surgery at Stanford University.
From 2003-2013, Dr. Holsinger worked at the Department of Head and Neck Surgery at the University of Texas M.D. Anderson Cancer Center where he founded and led the Program in Minimally Invasive and Endoscopic Head and Neck Surgery and co-directed the program in Minimally Invasive Technology in Oncologic Surgery.
In 2013, Dr. Holsinger moved to Stanford University, where at the Cancer Center led H&N Multidisciplinary Cancer Care Clinical Program for the next 5 years. Dr. Holsinger’s surgical practice focuses on the surgical management of thyroid as well as head and neck cancer. His areas of research interest include endoscopic head and neck surgery, including transoral robotic surgery and transoral laser microsurgery, as well as time-honoured approaches of conservation laryngeal surgery and supracricoid partial laryngectomy.
Dr Holsinger's research focuses on surgical innovation and clinical trials.
He serves as surgical principal investigator for RTOG920 and coordinated surgeon-credentialing for ECOG 3311, a prospective clinical trial to study robotic head and neck surgery. He recently led an investigative device exemption trial to evaluate the safety and efficacy of a next-generation flexible robotic surgical system which led to FDA approval of the Single-Port Robot in March 2019.
His interests extend beyond robotics, however, and include new technologies for augmenting the vision of surgeons and incorporating machine learning and AI into routine surgical practice. Current algorithms in computer vision and pattern recognition have transformed how we interact with the world using our smart phones. His lab aims to deliver these advantages to patient and their surgeons by providing real-time intelligence about surgical anatomy that extends beyond human vision. In the lab, he is studying multispectral and hyperspectral sensors and machine-learning algorithms to improve and develop novel technologies in surgical vision. In 2016, he began a prospective clinical trial to evaluate multispectral imaging of patients with oropharyngeal cancer, in an effort to discern tumor from tumor, as well as to evaluate hyper-spectral imaging to improve surgical vision.
In 2017, he founded Photonic Medical Technologies to translate recent innovations into practice for open surgery.
Dr. Holsinger received his medical degree from Vanderbilt School of Medicine, completed his internship and residency at Baylor College of Medicine and his Fellowship in head and neck surgical oncology at The University of Texas M. D. Anderson Cancer Center. In 2003, he was awarded Fulbright Scholarship to study surgery at the University of Paris with Professor Ollivier Laccourreye and with Professor Wolfgang Steiner at the Georg-August University in Göttingen.
Board-certified by the American Board of Otolaryngology, Dr. Holsinger is a member of numerous societies including the American College of Surgeons, American Head and Neck Society, the American Thyroid Association, and the American Society of Clinical Oncology.
